-
Je něco špatně v tomto záznamu ?
Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop
LE. Creary, SG. Guerra, W. Chong, CJ. Brown, TR. Turner, J. Robinson, WP. Bultitude, NP. Mayor, SGE. Marsh, K. Saito, K. Lam, JL. Duke, TL. Mosbruger, D. Ferriola, D. Monos, A. Willis, M. Askar, G. Fischer, CL. Saw, J. Ragoussis, M. Petrek, C....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
U19 NS095774
NINDS NIH HHS - United States
- MeSH
- alely MeSH
- B-lymfocyty virologie MeSH
- exony genetika MeSH
- genetická variace MeSH
- genetické lokusy MeSH
- genotyp MeSH
- haplotypy genetika MeSH
- histokompatibilita - antigeny třídy I genetika MeSH
- histokompatibilita - antigeny třídy II genetika MeSH
- histokompatibilita MeSH
- HLA antigeny genetika MeSH
- homozygot MeSH
- jednoduchá slepá metoda MeSH
- lidé MeSH
- sekvenční analýza DNA metody MeSH
- správnost dat MeSH
- testování histokompatibility metody MeSH
- transformované buněčné linie MeSH
- virová transformace buněk MeSH
- virus Epsteinův-Barrové imunologie MeSH
- vysoce účinné nukleotidové sekvenování metody MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Extended molecular characterization of HLA genes in the IHWG reference B-lymphoblastoid cell lines (B-LCLs) was one of the major goals for the 17th International HLA and Immunogenetics Workshop (IHIW). Although reference B-LCLs have been examined extensively in previous workshops complete high-resolution typing was not completed for all the classical class I and class II HLA genes. To address this, we conducted a single-blind study where select panels of B-LCL genomic DNA samples were distributed to multiple laboratories for HLA genotyping by next-generation sequencing methods. Identical cell panels comprised of 24 and 346 samples were distributed and typed by at least four laboratories in order to derive accurate consensus HLA genotypes. Overall concordance rates calculated at both 2- and 4-field allele-level resolutions ranged from 90.4% to 100%. Concordance for the class I genes ranged from 91.7 to 100%, whereas concordance for class II genes was variable; the lowest observed at HLA-DRB3 (84.2%). At the maximum allele-resolution 78 B-LCLs were defined as homozygous for all 11 loci. We identified 11 novel exon polymorphisms in the entire cell panel. A comparison of the B-LCLs NGS HLA genotypes with the HLA genotypes catalogued in the IPD-IMGT/HLA Database Cell Repository, revealed an overall allele match at 68.4%. Typing discrepancies between the two datasets were mostly due to the lower-resolution historical typing methods resulting in incomplete HLA genotypes for some samples listed in the IPD-IMGT/HLA Database Cell Repository. Our approach of multiple-laboratory NGS HLA typing of the B-LCLs has provided accurate genotyping data. The data generated by the tremendous collaborative efforts of the 17th IHIW participants is useful for updating the current cell and sequence databases and will be a valuable resource for future studies.
Anthony Nolan Research Institute Royal Free Hospital London UK
Biomedical Research Foundation Academy of Athens Hellenic Cord Blood Bank Athens Greece
Department of Histocompatibility and Immunogenetics NHS Blood and Transplant London UK
Department of Pathology and Lab Medicine University of Pennsylvania Philadelphia PA USA
Department of Pathology and Laboratory Medicine Baylor University Medical Center Dallas USA
Department of Pathology and Laboratory Medicine UCLA Immunogenetics Center Los Angeles CA USA
Department of Pathology Stanford University School of Medicine Palo Alto CA USA
Department of Pathology University of California San Diego La Jolla CA USA
Fred Hutchinson Cancer Research Center Seattle WA USA
Health Sciences Center Kuwait University Kuwait
HLA Department Kashi Clinical Laboratories Inc Portland OR USA
HLA Laboratory American Red Cross Philadelphia PA USA
HLA Laboratory City of Hope Duarte CA USA
HLA Laboratory Division of Haematology McGill University Health Centre Montreal Canada
Immunogenetics Laboratory The Children's Hospital of Philadelphia Philadelphia PA USA
Immunology Department Hospital Clinic de Barcelona University of Barcelona IDIBAPS Barcelona Spain
Laboratory of Translational Immunology UMC Utrecht Utrecht Netherlands
Molecular Biology Research Department One Lambda Thermo Fisher Scientific Canoga Park CA USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19044951
- 003
- CZ-PrNML
- 005
- 20200114085659.0
- 007
- ta
- 008
- 200109s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.humimm.2019.03.001 $2 doi
- 035 __
- $a (PubMed)30844424
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Creary, Lisa E $u Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA; Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA. Electronic address: lcreary@stanford.edu.
- 245 10
- $a Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop / $c LE. Creary, SG. Guerra, W. Chong, CJ. Brown, TR. Turner, J. Robinson, WP. Bultitude, NP. Mayor, SGE. Marsh, K. Saito, K. Lam, JL. Duke, TL. Mosbruger, D. Ferriola, D. Monos, A. Willis, M. Askar, G. Fischer, CL. Saw, J. Ragoussis, M. Petrek, C. Serra-Pagés, M. Juan, C. Stavropoulos-Giokas, A. Dinou, R. Ameen, S. Al Shemmari, E. Spierings, K. Gendzekhadze, GP. Morris, Q. Zhang, Z. Kashi, S. Hsu, S. Gangavarapu, KC. Mallempati, F. Yamamoto, K. Osoegawa, T. Vayntrub, CJ. Chang, JA. Hansen, MA. Fernández-Viňa,
- 520 9_
- $a Extended molecular characterization of HLA genes in the IHWG reference B-lymphoblastoid cell lines (B-LCLs) was one of the major goals for the 17th International HLA and Immunogenetics Workshop (IHIW). Although reference B-LCLs have been examined extensively in previous workshops complete high-resolution typing was not completed for all the classical class I and class II HLA genes. To address this, we conducted a single-blind study where select panels of B-LCL genomic DNA samples were distributed to multiple laboratories for HLA genotyping by next-generation sequencing methods. Identical cell panels comprised of 24 and 346 samples were distributed and typed by at least four laboratories in order to derive accurate consensus HLA genotypes. Overall concordance rates calculated at both 2- and 4-field allele-level resolutions ranged from 90.4% to 100%. Concordance for the class I genes ranged from 91.7 to 100%, whereas concordance for class II genes was variable; the lowest observed at HLA-DRB3 (84.2%). At the maximum allele-resolution 78 B-LCLs were defined as homozygous for all 11 loci. We identified 11 novel exon polymorphisms in the entire cell panel. A comparison of the B-LCLs NGS HLA genotypes with the HLA genotypes catalogued in the IPD-IMGT/HLA Database Cell Repository, revealed an overall allele match at 68.4%. Typing discrepancies between the two datasets were mostly due to the lower-resolution historical typing methods resulting in incomplete HLA genotypes for some samples listed in the IPD-IMGT/HLA Database Cell Repository. Our approach of multiple-laboratory NGS HLA typing of the B-LCLs has provided accurate genotyping data. The data generated by the tremendous collaborative efforts of the 17th IHIW participants is useful for updating the current cell and sequence databases and will be a valuable resource for future studies.
- 650 _2
- $a alely $7 D000483
- 650 _2
- $a B-lymfocyty $x virologie $7 D001402
- 650 _2
- $a transformované buněčné linie $7 D002461
- 650 _2
- $a virová transformace buněk $7 D002472
- 650 _2
- $a správnost dat $7 D000068598
- 650 _2
- $a exony $x genetika $7 D005091
- 650 _2
- $a genetické lokusy $7 D056426
- 650 _2
- $a genetická variace $7 D014644
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a HLA antigeny $x genetika $7 D006680
- 650 _2
- $a haplotypy $x genetika $7 D006239
- 650 _2
- $a virus Epsteinův-Barrové $x imunologie $7 D004854
- 650 _2
- $a vysoce účinné nukleotidové sekvenování $x metody $7 D059014
- 650 _2
- $a histokompatibilita $7 D006648
- 650 _2
- $a histokompatibilita - antigeny třídy I $x genetika $7 D015395
- 650 _2
- $a histokompatibilita - antigeny třídy II $x genetika $7 D000949
- 650 _2
- $a testování histokompatibility $x metody $7 D006650
- 650 _2
- $a homozygot $7 D006720
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a sekvenční analýza DNA $x metody $7 D017422
- 650 _2
- $a jednoduchá slepá metoda $7 D016037
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Guerra, Sandra G $u Histocompatibility and Immunogenetics Service Development Laboratory, NHS Blood and Transplant, London, UK.
- 700 1_
- $a Chong, Winnie $u Histocompatibility and Immunogenetics Service Development Laboratory, NHS Blood and Transplant, London, UK.
- 700 1_
- $a Brown, Colin J $u Department of Histocompatibility and Immunogenetics, NHS Blood and Transplant, London, UK.
- 700 1_
- $a Turner, Thomas R $u Anthony Nolan Research Institute, Royal Free Hospital, London, UK; UCL Cancer Institute, Royal Free Campus, London, UK.
- 700 1_
- $a Robinson, James $u Anthony Nolan Research Institute, Royal Free Hospital, London, UK; UCL Cancer Institute, Royal Free Campus, London, UK.
- 700 1_
- $a Bultitude, Will P $u Anthony Nolan Research Institute, Royal Free Hospital, London, UK; UCL Cancer Institute, Royal Free Campus, London, UK.
- 700 1_
- $a Mayor, Neema P $u Anthony Nolan Research Institute, Royal Free Hospital, London, UK; UCL Cancer Institute, Royal Free Campus, London, UK.
- 700 1_
- $a Marsh, Steven G E $u Anthony Nolan Research Institute, Royal Free Hospital, London, UK; UCL Cancer Institute, Royal Free Campus, London, UK.
- 700 1_
- $a Saito, Katsuyuki $u Molecular Biology Research Department, One Lambda, Thermo Fisher Scientific, Canoga Park, CA, USA.
- 700 1_
- $a Lam, Kevin $u Molecular Biology Research Department, One Lambda, Thermo Fisher Scientific, Canoga Park, CA, USA.
- 700 1_
- $a Duke, Jamie L $u Immunogenetics Laboratory, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
- 700 1_
- $a Mosbruger, Timothy L $u Immunogenetics Laboratory, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
- 700 1_
- $a Ferriola, Deborah $u Immunogenetics Laboratory, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
- 700 1_
- $a Monos, Dimitrios $u Immunogenetics Laboratory, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pathology and Lab Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- 700 1_
- $a Willis, Amanda $u Department of Pathology and Laboratory Medicine, Baylor University Medical Center, Dallas, USA.
- 700 1_
- $a Askar, Medhat $u Department of Pathology and Laboratory Medicine, Baylor University Medical Center, Dallas, USA.
- 700 1_
- $a Fischer, Gottfried $u Department for Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.
- 700 1_
- $a Saw, Chee Loong $u HLA Laboratory, Division of Haematology, McGill University Health Centre, Montreal, Canada.
- 700 1_
- $a Ragoussis, Jiannis $u Department of Human Genetics, McGill University & McGill University and Genome Quèbec Innovation Centre, Montreal, Canada.
- 700 1_
- $a Petrek, Martin $u Department of Pathological Physiology and Immunogenomics, IMTM, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
- 700 1_
- $a Serra-Pagés, Carles $u Immunology Department, Hospital Clinic de Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain.
- 700 1_
- $a Juan, Manel $u Immunology Department, Hospital Clinic de Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain.
- 700 1_
- $a Stavropoulos-Giokas, Catherine $u Biomedical Research Foundation Academy of Athens, Hellenic Cord Blood Bank, Athens, Greece.
- 700 1_
- $a Dinou, Amalia $u Biomedical Research Foundation Academy of Athens, Hellenic Cord Blood Bank, Athens, Greece.
- 700 1_
- $a Ameen, Reem $u Health Sciences Center, Kuwait University, Kuwait.
- 700 1_
- $a Al Shemmari, Salem $u Health Sciences Center, Kuwait University, Kuwait.
- 700 1_
- $a Spierings, Eric $u Laboratory of Translational Immunology, UMC Utrecht, Utrecht, Netherlands.
- 700 1_
- $a Gendzekhadze, Ketevan $u HLA Laboratory, City of Hope, Duarte, CA, USA.
- 700 1_
- $a Morris, Gerald P $u Department of Pathology, University of California San Diego, La Jolla, CA, USA.
- 700 1_
- $a Zhang, Qiuheng $u Department of Pathology and Laboratory Medicine, UCLA Immunogenetics Center, Los Angeles, CA, USA.
- 700 1_
- $a Kashi, Zahra $u HLA Department, Kashi Clinical Laboratories, Inc., Portland, OR, USA.
- 700 1_
- $a Hsu, Susan $u HLA Laboratory, American Red Cross, Philadelphia, PA, USA.
- 700 1_
- $a Gangavarapu, Sridevi $u Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.
- 700 1_
- $a Mallempati, Kalyan C $u Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.
- 700 1_
- $a Yamamoto, Fumiko $u Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.
- 700 1_
- $a Osoegawa, Kazutoyo $u Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.
- 700 1_
- $a Vayntrub, Tamara $u Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.
- 700 1_
- $a Chang, Chia-Jung $u Stanford Genome Technology Center, Palo Alto, CA, USA.
- 700 1_
- $a Hansen, John A $u Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
- 700 1_
- $a Fernández-Viňa, Marcelo A $u Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA; Histocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.
- 773 0_
- $w MED00002076 $t Human immunology $x 1879-1166 $g Roč. 80, č. 7 (2019), s. 449-460
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30844424 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200114090032 $b ABA008
- 999 __
- $a ok $b bmc $g 1483220 $s 1083624
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 80 $c 7 $d 449-460 $e 20190304 $i 1879-1166 $m Human immunology $n Hum Immunol $x MED00002076
- GRA __
- $a U19 NS095774 $p NINDS NIH HHS $2 United States
- LZP __
- $a Pubmed-20200109